BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Berentsen S, Barcellini W, D'Sa S, Jilma B. Sutimlimab for treatment of cold agglutinin disease: why, how and for whom? Immunotherapy 2022. [PMID: 35946351 DOI: 10.2217/imt-2022-0085] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Coyle L. Celebrating the 15th anniversary of Immunotherapy: a reflection on 2022. Immunotherapy 2023. [PMID: 36700701 DOI: 10.2217/imt-2022-0291] [Reference Citation Analysis]
2 Berentsen S, D’sa S, Randen U, Małecka A, Vos JMI. Cold Agglutinin Disease: Improved Understanding of Pathogenesis Helps Define Targets for Therapy. Hemato 2022;3:574-594. [DOI: 10.3390/hemato3040040] [Reference Citation Analysis]